Navigation Links
New antibiotic already developing resistance

An anti biotic, just a year old, which was developed to fight resistant bacteria, is already becoming stale as the bacteria are showing signs of resistance.

The drug linezolid is used to treat Enterococcus faecium (E. faecium) infections that are resistant to the old standby antibiotic vancomycin. The hope has been that the new drug would help tackle the growing problem of vancomycin-resistant enterococci infections. But in the April 14th issue of The Lancet, Chicago doctors report on five cases in which patients' infections became resistant to linezolid, as well.

Antibiotic resistance is a major problem worldwide, and hospitals are ground zero since infections and antibiotics are part of everyday life in these settings. Bacteria have an innate ability to mutate, and when they are repeatedly exposed to an antibiotic, they learn to change themselves in order to evade the drug. Bacteria that cause diseases such as pneumonia, tuberculosis and meningitis have learned to outsmart standard treatments. Without new drugs, experts fear some bacterial infections will become untreatable.

Before 1989, no US hospitals had experienced vancomycin-resistant E. faecium infections. By 1993, however, more than 10% of these infections acquired in hospitals were resistant to treatment. Linezolid was approved in April 2000 for the treatment of vancomycin-resistant E. faecium. Hence, doctors advice a sensitivity test before starting a patient on linezolid.
'"/>




Page: 1

Related medicine news :

1. Gene clue to antibiotics
2. Excessive use of antibiotics for sore throat
3. E. coli strains resistant to a common antibiotic
4. Cost-effective antibiotics for sinusitis treatment
5. Treatment of antibiotics ineffectual in bronchitis
6. Eczema patients lack natural antibiotic in skin
7. Modified antibiotic may support fight cancer
8. Vaccine Reduces antibiotic-resistant infections in Children
9. Use of antibiotics in farms may increase ‘super bugs
10. Frequent use of antibiotics raises the risk of carrying resistant infections
11. Novel antibiotic dressing developed for improved wound healing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/25/2017)... ... 2017 , ... FCPX users now have the ability to sharpen a desired ... Color users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical ... tools users can visually see the color range effected with ease all within ...
(Date:2/24/2017)... ... , ... Only two months after the official release of The Private Collection ... XO Private has initiated a second print-run of its lavish luxury travel coffee table ... when open, weighs in at more than six kilos, retails at EUR 1,000 per ...
(Date:2/24/2017)... ... , ... Dr. Ronald E. Hawkins, vice president for academic ... A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of ... comes to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... hearing disabilities, it is so critically important that we all are aware of ... is why Mediaplanet is proud to announce the launch of its newest edition ...
(Date:2/24/2017)... , ... February 24, 2017 , ... With ProGlass Prism ... Pro X . Users have total control over position, rotation, distortion, edge softness, edge ... within Final Cut Pro X. , With ProGlass Prism users are given the tools ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Februar 2017 LG Innotek hat heute die ... Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... zwischen 200 und 280 nm und eignet sich damit für ... ihre DNA zerstört. Das Produkt von LG Innotek erzeugt ... ...
Breaking Medicine Technology: